article thumbnail

Benefits of Cannabis for Alzheimer’s disease

Alchimia

Finally, cannabinoids improve mood, appetite and sleep while reducing stress, anxiety and agressiveness. Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study. Published in Frontiers in Pharmacology magazine, March 2014. See studies #2, 3, 4).

article thumbnail

The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval?

Freedom Leaf

On July 23, the World Health Organization’s Expert Committee on Drug Dependence stated that “no public health problems have been associated with CBD use” and that “CBD has been found to be generally well tolerated with a good safety profile.” If you enjoyed this Freedom Leaf article, subscribe to the magazine today!

DEA 51
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AAFP ( American Academy of Family Physicians) Releases Marijuana, Cannabinoids Position Paper

Cannabis Law Report

Therefore, the AAFP advocates for further research into the overall safety and health effects of recreational use, as well as the effects of those laws on patient and societal health. The AAFP supports requirements testing current marijuana and cannabinoid products for safety, dosing, and product consistency. In the Exam Room.

article thumbnail

Press Release: Silo Wellness Opens Jamaican Ecotourism Psilocybin Microdosing Resort

Cannabis Law Report

I want to sleep under the stars while microdosing. And I want Silo’s clients to enjoy this God-given luxury that experienced psychedelic users can do on their own, but in the safety and comfort of secure accommodations under the cover our of risk mitigation protocols.” I want to hear a tropical storm.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Our research focuses on discourse about cannabis in several major medical journals and magazines for Australian doctors.

article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

David John Nutt is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. Through its discovery platform, Delix has identified a class of non-hallucinogenic versions of psychedelic compounds with favorable safety and therapeutic profiles.

article thumbnail

Joe Biden thinks ‘forced rehab’ is positive drug reform. Here’s why he’s wrong

SpeedWeed

According to the DPA report, drug courts “have not demonstrated cost savings, reduced incarceration, or improved public safety,” but they do make “the criminal justice system more punitive toward addiction—not less; while leaving many people worse off for trying.”. The drug treatment industry’s shoddy record.